Literature DB >> 1353754

Activation of the mouse proliferating cell nuclear antigen gene promoter by adenovirus type 12 E1A proteins.

M Yamaguchi1, Y Hayashi, F Hirose, S Matsuoka, K Shiroki, A Matsukage.   

Abstract

A plasmid carrying the 5'-flanking region (-1584 to +47 with respect to the transcription initiation site) of the mouse proliferating cell nuclear antigen (PCNA) gene was fused with the chloramphenicol acetyltransferase (CAT) gene, and then cotransfected into mouse N18TG2 cells with expression plasmids for the adenovirus type 12 E1 genes. Expression of E1A gene products elevated the CAT expression by 5- to 9-fold, but expression of the E1B gene product did not. RNase protection analysis revealed that the activation of the PCNA gene promoter by E1A was at the transcription step. Both the 13S E1A and the 12S E1A activated the PCNA gene promoter, indicating that the activation domain of E1A resides in a common region(s) of 13S and 12S E1A products. The major target region of E1A was mapped within the 68 base-pair region (-21 to +47) of the PCNA gene, which includes consensus sequences for transcription factors PEA3 and E2F, although the upstream region (-83 to -21) including ATF(CREB)-binding consensus had an additional effect in the transactivation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1353754      PMCID: PMC5918878          DOI: 10.1111/j.1349-7006.1992.tb00133.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  42 in total

Review 1.  E1a revisited: the case for multiple cooperative trans-activation domains.

Authors:  A W Braithwaite; C C Nelson; A J Bellett
Journal:  New Biol       Date:  1991-01

Review 2.  Trans-acting protein factors and the regulation of eukaryotic transcription: lessons from studies on DNA tumor viruses.

Authors:  N C Jones; P W Rigby; E B Ziff
Journal:  Genes Dev       Date:  1988-03       Impact factor: 11.361

3.  Activation of gene expression by adenovirus and herpesvirus regulatory genes acting in trans and by a cis-acting adenovirus enhancer element.

Authors:  M J Imperiale; L T Feldman; J R Nevins
Journal:  Cell       Date:  1983-11       Impact factor: 41.582

4.  Mouse DNA polymerase beta gene promoter: fine mapping and involvement of Sp1-like mouse transcription factor in its function.

Authors:  M Yamaguchi; Y Hayashi; A Matsukage
Journal:  Nucleic Acids Res       Date:  1988-09-26       Impact factor: 16.971

5.  Structure of the human gene for the proliferating cell nuclear antigen.

Authors:  S Travali; D H Ku; M G Rizzo; L Ottavio; R Baserga; B Calabretta
Journal:  J Biol Chem       Date:  1989-05-05       Impact factor: 5.157

6.  Human beta-polymerase gene. Structure of the 5'-flanking region and active promoter.

Authors:  S G Widen; P Kedar; S H Wilson
Journal:  J Biol Chem       Date:  1988-11-15       Impact factor: 5.157

7.  Cloning and sequence of the human nuclear protein cyclin: homology with DNA-binding proteins.

Authors:  J M Almendral; D Huebsch; P A Blundell; H Macdonald-Bravo; R Bravo
Journal:  Proc Natl Acad Sci U S A       Date:  1987-03       Impact factor: 11.205

8.  Regulation of the proliferating cell nuclear antigen cyclin and thymidine kinase mRNA levels by growth factors.

Authors:  D Jaskulski; C Gatti; S Travali; B Calabretta; R Baserga
Journal:  J Biol Chem       Date:  1988-07-25       Impact factor: 5.157

9.  Molecular cloning, structure and expression of the yeast proliferating cell nuclear antigen gene.

Authors:  G A Bauer; P M Burgers
Journal:  Nucleic Acids Res       Date:  1990-01-25       Impact factor: 16.971

10.  Functions of replication factor C and proliferating-cell nuclear antigen: functional similarity of DNA polymerase accessory proteins from human cells and bacteriophage T4.

Authors:  T Tsurimoto; B Stillman
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

View more
  7 in total

1.  Characterization of the nonmuscle myosin heavy chain IIB promoter: regulation by E2F.

Authors:  L Weir; D Chen
Journal:  Gene Expr       Date:  1996

2.  Inhibition of mesangial cell proliferation by E2F decoy oligodeoxynucleotide in vitro and in vivo.

Authors:  Y Maeshima; N Kashihara; T Yasuda; H Sugiyama; T Sekikawa; K Okamoto; K Kanao; Y Watanabe; Y S Kanwar; H Makino
Journal:  J Clin Invest       Date:  1998-06-01       Impact factor: 14.808

3.  Cellular targets for activation by the E2F1 transcription factor include DNA synthesis- and G1/S-regulatory genes.

Authors:  J DeGregori; T Kowalik; J R Nevins
Journal:  Mol Cell Biol       Date:  1995-08       Impact factor: 4.272

Review 4.  Transcription factor decoy oligonucleotide-based therapeutic strategy for renal disease.

Authors:  Naruya Tomita; Naoki Kashihara; Ryuichi Morishita
Journal:  Clin Exp Nephrol       Date:  2007-03-28       Impact factor: 2.801

5.  A gene therapy strategy using a transcription factor decoy of the E2F binding site inhibits smooth muscle proliferation in vivo.

Authors:  R Morishita; G H Gibbons; M Horiuchi; K E Ellison; M Nakama; L Zhang; Y Kaneda; T Ogihara; V J Dzau
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-20       Impact factor: 11.205

Review 6.  MCB elements and the regulation of DNA replication genes in yeast.

Authors:  E M McIntosh
Journal:  Curr Genet       Date:  1993-09       Impact factor: 3.886

Review 7.  Transcriptional regulation of DNA replication-related genes in cell growth, differentiation and oncogenesis.

Authors:  A Matsukage; F Hirose; M Yamaguchi
Journal:  Jpn J Cancer Res       Date:  1994-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.